AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 85 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $18,037,200 | +1.9% | 450,930 | +11.9% | 0.00% | 0.0% |
Q1 2024 | $17,697,488 | -28.6% | 403,040 | +0.5% | 0.00% | -33.3% |
Q4 2023 | $24,794,985 | +31.3% | 400,889 | -2.4% | 0.01% | +20.0% |
Q3 2023 | $18,884,829 | -41.4% | 410,629 | -26.8% | 0.01% | -37.5% |
Q2 2023 | $32,221,934 | +45.0% | 560,674 | -5.4% | 0.01% | +33.3% |
Q1 2023 | $22,228,839 | +22.8% | 592,769 | -8.2% | 0.01% | +20.0% |
Q4 2022 | $18,099,772 | +9.5% | 645,959 | +9.9% | 0.01% | 0.0% |
Q3 2022 | $16,522,000 | -6.9% | 587,943 | +15.3% | 0.01% | 0.0% |
Q2 2022 | $17,744,000 | -32.6% | 510,047 | -30.5% | 0.01% | -28.6% |
Q1 2022 | $26,344,000 | +62.3% | 733,842 | +5.3% | 0.01% | +75.0% |
Q4 2021 | $16,230,000 | +19.5% | 696,889 | -2.4% | 0.00% | +33.3% |
Q3 2021 | $13,579,000 | -14.6% | 714,319 | -9.4% | 0.00% | -25.0% |
Q2 2021 | $15,895,000 | -7.1% | 788,414 | -15.6% | 0.00% | -20.0% |
Q1 2021 | $17,104,000 | -39.0% | 933,646 | -33.1% | 0.01% | -37.5% |
Q4 2020 | $28,055,000 | +10.8% | 1,395,047 | +3.3% | 0.01% | -11.1% |
Q3 2020 | $25,320,000 | -11.2% | 1,350,417 | +6.4% | 0.01% | -10.0% |
Q2 2020 | $28,499,000 | +158.8% | 1,268,877 | +71.0% | 0.01% | +100.0% |
Q1 2020 | $11,013,000 | -48.1% | 742,147 | -32.6% | 0.01% | -28.6% |
Q4 2019 | $21,238,000 | +58.7% | 1,100,992 | +63.1% | 0.01% | +75.0% |
Q3 2019 | $13,385,000 | +126.5% | 674,980 | +141.1% | 0.00% | +100.0% |
Q2 2019 | $5,909,000 | -66.6% | 279,907 | -67.7% | 0.00% | -66.7% |
Q1 2019 | $17,708,000 | -20.0% | 866,785 | -22.1% | 0.01% | -25.0% |
Q4 2018 | $22,146,000 | +127.7% | 1,112,867 | +120.2% | 0.01% | +166.7% |
Q3 2018 | $9,725,000 | +106.6% | 505,438 | +63.9% | 0.00% | +50.0% |
Q2 2018 | $4,707,000 | -74.9% | 308,474 | -69.2% | 0.00% | -71.4% |
Q1 2018 | $18,765,000 | -3.5% | 1,000,797 | -1.0% | 0.01% | 0.0% |
Q4 2017 | $19,447,000 | -18.6% | 1,010,740 | -24.4% | 0.01% | -22.2% |
Q3 2017 | $23,880,000 | +0.4% | 1,336,330 | +0.4% | 0.01% | +28.6% |
Q2 2017 | $23,782,000 | +732.4% | 1,331,600 | +575.9% | 0.01% | +600.0% |
Q1 2017 | $2,857,000 | +8.3% | 197,020 | +37.5% | 0.00% | 0.0% |
Q4 2016 | $2,639,000 | -12.9% | 143,289 | -10.3% | 0.00% | 0.0% |
Q3 2016 | $3,030,000 | +835.2% | 159,753 | +695.2% | 0.00% | – |
Q2 2016 | $324,000 | +26.1% | 20,089 | -6.4% | 0.00% | – |
Q1 2016 | $257,000 | +5040.0% | 21,453 | +6887.9% | 0.00% | – |
Q2 2015 | $5,000 | – | 307 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Summit Global Investments | 58,640 | $870,000 | 0.13% |
FEDERATED HERMES, INC. | 2,600,120 | $38,586,000 | 0.11% |
ROTHSCHILD & CO ASSET MANAGEMENT US INC. | 284,328 | $4,219,000 | 0.07% |
SILVERCREST ASSET MANAGEMENT GROUP LLC | 291,352 | $4,324,000 | 0.05% |
MARSHALL WACE, LLP | 301,910 | $4,481,000 | 0.04% |
MARTINGALE ASSET MANAGEMENT L P | 212,817 | $3,159,000 | 0.04% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 171,266 | $2,542,000 | 0.03% |
WINTON GROUP Ltd | 82,402 | $1,223,000 | 0.03% |
EAGLE ASSET MANAGEMENT INC | 317,988 | $4,718,000 | 0.03% |
Engineers Gate Manager LP | 24,007 | $356,000 | 0.03% |